These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3486754)

  • 1. Penetration of amoxycillin and clavulanic acid into bone.
    Grimer RJ; Karpinski MR; Andrews JM; Wise R
    Chemotherapy; 1986; 32(3):185-91. PubMed ID: 3486754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children.
    Schaad UB; Casey PA; Ravenscroft AT
    J Antimicrob Chemother; 1986 Mar; 17(3):341-5. PubMed ID: 3700293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of amoxycillin/clavulanate into human bone.
    Weismeier K; Adam D; Heilmann HD; Koeppe P
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():93-100. PubMed ID: 2606824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The penetration of amoxycillin/clavulanic acid into peritoneal fluid.
    Wise R; Donovan IA; Drumm J; Andrews JM; Stephenson P
    J Antimicrob Chemother; 1983 Jan; 11(1):57-60. PubMed ID: 6826486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxycillin/clavulanic acid: the effect of probenecid.
    Staniforth DH; Jackson D; Clarke HL; Horton R
    J Antimicrob Chemother; 1983 Sep; 12(3):273-5. PubMed ID: 6630111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.
    Witkowski G; Lode H; Höffken G; Koeppe P
    Eur J Clin Microbiol; 1982 Aug; 1(4):233-7. PubMed ID: 7173186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Baur C
    J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentin bioavailability following cimetidine, aluminum hydroxide and milk.
    Staniforth DH; Clarke HL; Horton R; Jackson D; Lau D
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):154-7. PubMed ID: 3838971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
    Soback S; Bor A; Kurtz B; Paz R; Ziv G
    J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.
    Wise R; Bennett SA; Dent J
    J Antimicrob Chemother; 1984 Jun; 13(6):603-10. PubMed ID: 6469882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.
    Nilsson-Ehle I; Fellner H; Hedström SA; Nilsson-Ehle P; Sjövall J
    J Antimicrob Chemother; 1985 Oct; 16(4):491-8. PubMed ID: 4066561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen LW
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients.
    Grange JD; Gouyette A; Gutmann L; Amiot X; Kitzis MD; Islam S; Acar JF; Jaillon P
    J Antimicrob Chemother; 1989 Apr; 23(4):605-11. PubMed ID: 2745264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1983 Mar; 36(3):481-6. PubMed ID: 6876360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.